Not logged in.png)
Share.png)
SaveCathepsin S contributes to influenza-induced lung injury by driving inflammation, promoting apoptosis, and disrupting epithelial barrier integrity
Ma, Tianxin; Yang, Chunguang; Wang, Yang; Tu, Chuanmeizi; Zhang, Jiawei; Mai, Kailin; Wu, Shengzhen; Zhou, Hongxuan; Li, Shengfeng; Ye, Sulan; Liang, Lixi; Huang, Qingsheng; Zhang, Zhenhui; Lin, Zhengshi; Pan, Weiqi; Yang, Zifeng Share Save Share Save Share Save Comparative Structure Activity Relationship Characterization of the Biosimilar BAT1806/BIIB800 to Reference TocilizumabLiu, Yujie; Xie, Jianhua; Li, Zhuxiang; Mei, Xiong; Cao, Di; Li, Shengfeng; Engle, Linda; Liu, Suli; Ebbers, Hans C.; Liu, Cuihua Share Save Share Save Fate and potential ecological risk of rare earth elements in 3000-year reclaimed soil chronosequencesZhang, Yalu; Ji, Jiachen; Su, Baowei; Xu, Mingxu; Wang, Yonghong; Jiao, He; Li, Ning; Zhang, Huan; Li, Shengfeng; Wu, Jingtao; Gao, Chao Share Save Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab (vol 38, pg 571, 2024)Liu, Yujie; Xie, Jianhua; Li, Zhuxiang; Mei, Xiong; Cao, Di; Li, Shengfeng; Engle, Linda; Liu, Suli; Ebbers, Hans C.; Liu, Cuihua Share Save Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference TocilizumabLiu, Yujie; Xie, Jianhua; Li, Zhuxiang; Mei, Xiong; Cao, Di; Li, Shengfeng; Engle, Linda; Liu, Suli; Ebbers, Hans C.; Liu, Cuihua Share Save Soil bacterial succession with different land uses along a millennial chronosequence derived from the Yangtze River flood plainSu, Baowei; Gao, Chao; Ji, Jiachen; Zhang, Huan; Zhang, Yalu; Mouazen, Abdul M.; Shao, Shuangshuang; Jiao, He; Yi, Shuangwen; Li, Shengfeng Share Save BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapyLiang, Shizhong; Zheng, Dandan; Liu, Xiong; Mei, Xiong; Zhou, Congcong; Xiao, Cuizhen; Qin, Chao; Yue, Haitao; Lin, Jian; Liu, Cuihua; Li, Shengfeng; Yu, Jin-Chen Share Save Share Save A phase I study of BAT1006, a novel anti-HER2 antibody, in patients with locally advanced/metastatic solid tumorsMei, Xingxing; Tang, Weijia; Song, Shuqiang; Wang, Hao; Cao, Chuanqi; Feng, Cuiying; Thomas, Bert E.; Li, Shengfeng; Yu, Jin-Chen Share Save BAT8008, a novel Trop-2 ADC with strong bystander effect, for the treatment of Trop-2 positive cancerMei, Xingxing; Tang, Weijia; Zhou, Xin; Qi, Xuekang; Mai, Siqi; Zhong, Zhi; Li, Shuoxu; Fan, Jianjun; Gan, Jirong; Tan, Binghua; Qi, Yao; Guo, Yanling; Yu, Jin-Chen; Li, Shengfeng Share Save Share Save Share Save Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2-positive breast cancer: An open-label, dose-escalation, phase I studyHong, Ruoxi; Xia, Wen; Wang, Liye; Lee, Kaping; Lu, Qianyi; Jiang, Kuikui; Li, Shengfeng; Yu, Jinquan; Wei, Jin; Tang, Weijia; Zhou, Danyang; An, Xin; Huang, Jiajia; Xue, Cong; Bi, Xiwen; Shi, Yanxia; Yuan, Zhongyu; Xu, Fei; Wang, Shusen Share Save A Phase I, Randomized, Double-Blind, Single-Dose, Parallel-Group Study to compare Pharmacokinetic Similarity, Safety, and Immunogenicity Between BAT2506 and Golimumab in Healthy Chinese Male SubjectsWu, Min; Sun, Jixuan; Wu, Dandan; Xu, Jia; Wei, Jin; Wang, Zhaohe; Yu, Jinchen; Li, Shengfeng; Zhang, Hong; Ding, Yanhua Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
